Week In Review: Jacobson Pharma Raises $85 Million In Hong Kong IPO

Jacobson Pharma, Hong Kong's largest generic drug maker, completed an $85 million IPO on the Hong Kong exchange. The company says it will allocate 45% of the proceeds to strategic acquisitions.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.